Tradestie Institutional Equity Comparison Engine
IVA vs XOMA โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
XOMA Overall Edge
XOMA Captures Institutional Edge (4โ0 Pillars ยท 9โ1 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to XOMA Royalty Corporation Common Stock (XOMA) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, IVA trades at N/M Forward P/E with -5980.9% operating margin (-76.7% YoY revenue) versus XOMA at 21.5x Forward P/E and -3.9% operating margin (-22.6% YoY). In options structure, IVA sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against XOMA sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro).
Valuation Winner
XOMA
IVA N/M vs XOMA 21.5x Fwd P/E
Growth & Margin Winner
XOMA
Op Margin -5980.9% vs -3.9% ยท YoY -76.7% vs -22.6%
Momentum & Technical Winner
XOMA
1Y -13.0% vs +44.0% ยท 52W Pos 11% vs 78%
Options & Structure Winner
XOMA
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (100th %ile IV)
IVA
NASDAQ
Inventiva S.A. American Depository Shares
Pharmaceutical Preparations
$3.33
-9.65% 1D
Market Cap
$927.7M
1M Return
+13.1%
1Y Return
-12.96%
Forward P/E
N/M
Unified AI Score
38.6 / 100
SELL
Tech 38.0
Fund 36.0
Flow 50.0
Mom 21.1
XOMA
NASDAQ
XOMA Royalty Corporation Common Stock
Pharmaceutical Preparations
$40.17
-9.16% 1D
Market Cap
$781.8M
1M Return
-3.81%
1Y Return
+43.98%
Forward P/E
21.5x
Unified AI Score
55.8 / 100
HOLD
Tech 40.0
Fund 52.0
Flow 50.0
Mom 64.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
IVA -12.96%
XOMA +43.98%
Spread: +12.03 pp (XOMA Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
IVA TTM Op. Margin: -5980.9%
XOMA TTM Op. Margin: -3.9%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on IVA vs XOMA. Trailing 12-month operating profitability (IVA -5980.9% vs XOMA -3.9%) and valuation multiples (IVA N/M vs XOMA 21.5x Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | IVA | XOMA | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $927.7M | $781.8M | Larger Scale | IVA |
| Trailing P/E Ratio Valuation | N/M | 28.2x | Lower Multiple | XOMA |
| Forward P/E Ratio Valuation | N/M | 21.5x | Lower Multiple | XOMA |
| Revenue Growth (YoY) Growth | -76.7% | -22.6% | Higher Growth | XOMA |
| Operating Margin (TTM) Profitability | -5980.9% | -3.9% | Higher Margin | XOMA |
| Net Profit Margin Profitability | 0.0% | 69.6% | Higher Margin | XOMA |
| Return on Equity (ROE) Capital Efficiency | -989.0% | 34.2% | Higher ROE | XOMA |
| 52-Week Range Position Momentum | 11% ($3โ$7) | 78% ($22โ$45) | Stronger Trend | XOMA |
| Beta / 30D Volatility Risk Regime | 1.15ฮฒ ยท 75% Vol | 0.68ฮฒ ยท 37% Vol | Lower Realized Risk | XOMA |
| Unified Institutional Score Composite Signal | 38.6 / 100 (SELL) | 55.8 / 100 (HOLD) | Higher Composite | XOMA |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full IVA vs XOMA Buy Guide
IVA
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
XOMA
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
100th %ile
IV Regime
Extreme (>80th %ile)
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither IVA nor XOMA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.